GLP-1 drugsHumansPreprint14,364 participantsCohort study

Education and Alzheimer Disease Genetic Risk in Associations of GLP-1 Receptor Agonists With Dementia Among Adults With Type 2 Diabetes

medRxiv

The paper

Jingxuan Wang, Anna M. Pederson, Michael D. Flanders,

Minhyuk Choi, Peter T. Buto, Kendra D. Sims, Ruijia Chen, Elyse Couch, Paola Gilsanz, Kaleen N. Hayes, Andrew R. Zullo, Andrew Stokes, M. Maria Glymour,

Sarah F. Ackley

Boston University · Brown University

medRxiv · 8 Sep 2026 · Preprint, not peer-reviewed

doi.org/10.64898/2026.09.04.26362304 PubMed 42818421

SGLT2 inhibitors link to lower dementia risk than GLP-1 drugs
Diabetes & Vascular Disease Research · 4 Oct 2026
SGLT2 inhibitors match GLP-1 drugs for overall kidney outcomes
Clinical Journal of the American Society of Nephrology · 4 Oct 2026
GLP-1 receptor agonists link to lower stroke and Alzheimer risk
Neurology Genetics · 4 Oct 2026
COVID-19 tied to higher dementia risk in older adults with diabetes
Frontiers in Aging Neuroscience · 4 Oct 2026